Table 2.

Six most important outcomes of UK regulation and innovation which regulatory science needs to effectively enable.

Strategic outcomes
1	Flexibility: the capability of regulations to adapt to novel products and target patient outcomes
2	Co-development: collaboration across sectors, e.g. patients, manufacturers, regulators and educators working together to develop appropriate training for novel product deployment
3	Responsiveness: the preparation of frameworks which enable timely innovation required by emerging events
4	Speed: the rate at which new products can reach the market
5	Reimbursement: developing effective tools to track and evaluate outcomes for “pay for performance” products
6	Education and professional development